New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

2021/43/B/NZ7/01022

Keywords

Descriptors

  • NZ5_003: Patogeneza chorób człowieka
  • NZ5_007: Leczenie chorób człowieka
  • NZ7_016: Inne zagadnienia pokrewne

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Gdański Uniwersytet Medyczny, Wydział Lekarski

Voivodeship: pomorskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Anna Wardowska

Number of co-investigators in the project: 7

Call

OPUS 22 – announced on 2021-09-15

Amount awarded
1 904 664 PLN
Project start date
2022-07-15
Project end date
2027-07-14
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Peptides targeting the BTLA-HVEM complex can modulate T cell immune response

    Authors:
    Wojciechowicz K, Kuncewicz K, Lisowska KA, Wardowska A, Spodzieja M.
    Academic press:
    European Journal of Pharmaceutical (year: 2024, volume: 193, pages: 106677), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejps.2023.106677 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski